Infrequently used antidotes: indications and availability.
D017607:Aluminum Compounds; D000538:Aluminum Silicates / Q000008:administration & dosage; D000629:Aminopropionitrile / Q000008:administration & dosage / Q000031:analogs & derivatives; D000931:Antidotes / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D000997:Antivenins / Q000008:administration & dosage; D001120:Arginine / Q000008:administration & dosage; D002118:Calcium / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D004050:Ditiocarb / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D005295:Ferrocyanides / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D005989:Glycerides / Q000008:administration & dosage; D006801:Humans; D007616:Kaolin / Q000008:administration & dosage; D017616:Magnesium Compounds; D009536:Niacinamide / Q000008:administration & dosage; D010396:Penicillamine / Q000008:administration & dosage / Q000031:analogs & derivatives; D011092:Polyethylene Glycols / Q000008:administration & dosage; D017640:Silicates; D008063:Thioctic Acid / Q000008:administration & dosage
D017607:Aluminum Compounds; D000538:Aluminum Silicates; D000931:Antidotes; D000997:Antivenins; D005295:Ferrocyanides; D005989:Glycerides; D017616:Magnesium Compounds; D017640:Silicates; C027243:beta-aminopropionitrile fumarate; D000629:Aminopropionitrile; D007616:Kaolin; D009536:Niacinamide; D000431:Ethanol; D011092:Polyethylene Glycols; C010005:N-acetylpenicillamine; D008063:Thioctic Acid; D004317:Doxorubicin; C001262:Fuller's Earth; C038923:monoacetin; D001120:Arginine; D004050:Ditiocarb; D010396:Penicillamine; D002118:Calcium; C000170:ferric ferrocyanide; D005472:Fluorouracil; D002330:Carmustine